Charles Brenner, PhD, is the Department Chair at City of Hope, specializing in NAD metabolism, quantitative mass spectrometry, and metabolic diseases including fatty liver, diabesity, and cancer. Based in Los Angeles, he leads research efforts with a focus on scientific integrity and innovation in metabolic disease. His work integrates advanced biochemical techniques to advance understanding and treatment in these domains.

‌